Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Clin Epidemiol. 2011;3 Suppl 1(Suppl 1):59-64. doi: 10.2147/CLEP.S20621. Epub 2011 Jul 21.
To examine time trends of survival and mortality of ovarian cancer in the central and northern Denmark regions during the period 1998-2009.
We conducted a cohort study including women recorded with a first-time diagnosis of ovarian cancer in the Danish National Registry of Patients (DNRP) between 1998 and 2009. Patients were followed for survival through the Danish Civil Registration System. We determined survival stratified by age, and used Cox proportional hazard regression analyses to obtain mortality rate ratios (MRRs) to assess changes over time.
We found no improvement in overall ovarian cancer survival between 1998 and 2009. One-year survival was 71% in 1998-2000 and 68% in 2007-2009. Three-year survival declined from 48% in 1998-2000 to 46% in 2007-2009 (predicted), and 5-year survival declined from 40% in 1998-2000 to 37% in 2007-2009 (predicted). Compared with the period 1998-2000, the age-adjusted 1-year MRR was 1.05 (95% confidence interval CI: 0.86-1.28) for the period 2007-2009, and the predicted age-adjusted 3- and 5-year MRRs were 0.96 (95% CI: 0.83-1.12) and 0.99 (95% CI: 0.86-1.14), respectively. Results are not adjusted for tumor stage as this information was not available. We also observed a decline in the annual number of incident ovarian cancer patients during the study period, most pronounced in the youngest age group.
The survival of ovarian cancer patients did not improve during the study period. This lack of improvement contrasts with the national cancer strategies implemented during this last decade, focusing on improving the survival of ovarian cancer patients.
研究 1998-2009 年丹麦中部和北部地区卵巢癌患者的生存和死亡率的时间趋势。
我们进行了一项队列研究,纳入了 1998 年至 2009 年间在丹麦国家患者登记处(DNRP)首次诊断为卵巢癌的女性患者。通过丹麦民事登记系统对患者进行生存随访。我们按年龄分层确定生存情况,并使用 Cox 比例风险回归分析获得死亡率比值(MRR),以评估随时间的变化。
我们发现 1998 年至 2009 年期间卵巢癌总体生存率没有提高。1998-2000 年的 1 年生存率为 71%,2007-2009 年为 68%。3 年生存率从 1998-2000 年的 48%下降至 2007-2009 年的 46%(预测),5 年生存率从 1998-2000 年的 40%下降至 2007-2009 年的 37%(预测)。与 1998-2000 年相比,2007-2009 年调整年龄后的 1 年 MRR 为 1.05(95%置信区间 CI:0.86-1.28),预测调整年龄后的 3 年和 5 年 MRR 分别为 0.96(95% CI:0.83-1.12)和 0.99(95% CI:0.86-1.14)。由于没有肿瘤分期的信息,因此结果未进行调整。我们还观察到研究期间卵巢癌新发病例的年度数量下降,在最年轻的年龄组中最为明显。
在研究期间,卵巢癌患者的生存率没有提高。这与过去十年中实施的国家癌症策略形成鲜明对比,这些策略旨在提高卵巢癌患者的生存率。